Across its top 20 institutional holders, MOH's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 6/100, avg. turnover score 27/100).

Quarterly Activity

Recent Activity

+$4.9B

Total Buy Value

$4.4B

Total Sell Value

New buy121

Trim170

Add193

Sold out147

314

Net Buyers

317

Net Sellers

Smart Money Convergence

MOH does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

60855R100, 60855R950

FAQ

Who are the top institutional investors holding MOLINA HEALTHCARE INC (MOH)?

Major stakeholders currently include BlackRock, Inc. ($849.0M), FMR LLC ($427.2M), Capital World Investors ($426.5M). Based on the latest 13F filings, there are a total of 527 tracked investment funds and institutions maintaining positions in MOH.

What is the overall institutional sentiment toward MOH recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.9B, driven by 314 managers accumulating shares while 317 reduced their exposure.

Which institutions have been selling or reducing their MOH positions?

In the latest period, 170 funds trimmed their holdings, and 147 managers completely exited their positions. The aggregate reported sell value was $4.4B.

Are there any notable investors adding MOH to their portfolios?

Yes, buying activity remains notable. 121 institutions opened new positions in {ticker}, and 193 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.9B.